Spontaneous Bacterial Peritonitis in Alcoholic Cirrhosis
Main Article Content
Abstract
Background: Spontaneous bacterial peritonitis (SBP) is one of the most common complications in cirrhosis with ascites, which is associated with a high mortality. Various studies have shown that the prevalence of PBS ranges from 20-30% in patients with cirrhosis and ascites. Not in all cases it is accompanied by obvious symptoms, which makes early diagnosis difficult.
Aim: The aims of this study were to assess the prevalence and the risk factors of PBS in alcohoolic liver cirrhosis.
Methodology: This is a retrospective study, which considers all cases diagnosed with PBS admitted to our hospital during 2018-2021. Diagnosis is based on the European Association for the Study of Liver (EASL) guidelines. The patients were divided into two groups, alcohoolic cirrhosis with PBS, and without PBS. Data collection consists of filling out a standard form for each patient,which contained information about the diagnosis, the degree of liver function damage evaluated by Child-Pough score and MELD score, clinical and laboratory indicators and complications associated with cirrhosis with PBS, ascitic fluid analyses. All categorical variables were analised by using SPSS version 25, and t-test were used for continuous date.
Results: The average age of the patients included in the study was 54.15 ± 12.5 years, while according to gender, there were 112 males (97.3%) and 3 females (2.7%). According to the evaluation of MELD, it was seen to be higher in the group with PBS than those without PBS (p < 0.05). The most frequent complications accompanying PBS were Encephalopathy (p < 0.004), hepatorenal syndrome (p < 0.004), gastro\intestinal hemorrhage (p < 0.004). From laboratory data, platelets (p < 0.015), creatinine (p < 0.006), bilirubin (p < 0.002), INR (p < 0.049) and prothrombin level (p < 0.002) were seen as predictive factors.
Conclusions: The most probable predictive factors in the case of PBS in alcoholic cirrhosis were found the low level of platelets, prolonged level of INR and prothrombin, increased level of creatinine. While the most frequent associated complications were hepatic encephalopathy, HRS, G\I hemorrhage, jaundice.
Keywords: cirrhosis, PBS, complications, predictive
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
I. European Association for the Study of the Liver Electronic address: easloffice@easloffice.eu, EASL clinical practice guidelines for the management of patients with decompensated cirrhosis. J Hepatol. 2018;69(2):406–460.
II. 2.D, Amico G, The clinical course of cirrhosis. Population base studies and the need of personalized medicine. J Hepatol 2014; 60:241-242.
III. D, Amico G, Garsia-Tsao G, Pagliaro L. Natural history and prognostic indicators of survival in cirrhosis: a systemic review of 118 studies. J Hepatol 2006; 44:217-231.
IV. PianoS, Singh V, Caraceni P, et al. Epidemiology, predictors, and outcomes of multi drug resistant (MDR) bacterial infections in patients with cirrhosis across the world. Results of the "Global study" Dig Liver Dis. 2018;50 (1):2-3.
V. Fernandez J. Navasa M, Gomez J, Vila J, Arroyo V, et al. Bacterial infections in patients with cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis. Hepatology 2002:35:140-148.
VI. Piano.S, Fasolato S, Salinas F, Romano A, Tonon M, Morando F, et al. The empirical antibiotic treatment of nosocomial spontaneous bacterial peritonitis: Results of randomized, controlled clinical trial. Hepatology 2016; 63:1299-1309.
VII. J.Fernandez, V.Prado, J.Trebickaet al,"Multidrug-resistant bacterial infections in patients with decompensated cirrhosis and with acute-on-chronic liver failure in Europe. Journal of Hepatology, vol. 70, no. 3, pp. 398-411, 2019
VIII. 8.J. Fernandes, M.Navasa, J.Gomez et al; "Bacterial infections in cirrhosis: epidemiological changes with invasive procedures and norfloxacin prophylaxis", Hepatology, vol.35.no1, pp.140-148, 2002.
IX. JBDever and MYSheikh, "Spontaneous bacterial peritonitis-bacteriology, diagnosis, treatment, risk factors and prevention", Alimentary Pharmacology §Therapeutics, vol.41, no.11, pp.1116-1131, 2015.
X. Rimola A. Garsia - Tsao G, Navasa M, Piddock Lj, Planas R, Bernard B, et al, Diagnosis, treatment and prophylaxis of spontaneous bacterial peritonitis: a consensus document. International Ascites Club. J. Hepatol 2000; 32:142-153.
XI. 11. Evans LT, Kim UR, Poterucha JJ, Kamath PS, Spontaneous Bacterial Peritonitis in asymptomatic outpatients with cirrhotic ascites. Hepatology 2003; 37:897-901.
XII. Fleming C, Brouwer R, van Alphen A, Lindemans J, de Jonge R. UF-1000i: validation of the body fluid mode for counting cells in body fluids. Clin Chem LabMed 2014; 52:1781-1790.
XIII. Van de Geijn GM, van Gent M, van Pul-Bom N, Beunis MH, Van Tilburg AJ, Njo TL, A flow cytometric method for differential cell counting in ascetic fluid. Cytometry B Clin Cytom 2016; 90:506-511.
XIV. Mills SJ, Harrison SA. Comparison of the natural history of alcoholic and nonalcoholic fatty liver disease. Curr Gastroenterol Rep. 2005; 7:32–36.
XV. World Health Organization (WHO) Global status report on alcohol and health. 2014
XVI. Torruellas C, French SW, Medici V. Diagnosis of alcoholic liver disease. World J Gastroenterol. 2014 Sep 07;20(33):11684-99.
XVII. Sort P, Navasa M, Arroyo V, AldeguerX, Planas R, Ruiz-del-Arbo L, Castells L, Vargas V, Soriano G, Guevara MGines P, Rodes J. Effect of intravenous albumin on renal impairment and mortality in patients with cirrhosis and spontaneous bacterial peritonitis. N Engl J Med 1999:341(6):403-409.
XVIII. Filik L, Unal S. Clinical and laboratory features of spontaneous bacterial peritonitis. East Afr MoD J 2004; 81:474-79.
XIX. Hoefs JC, Canawati HN, Sapico FL, Hopkins RR, Weiner J, Montgomery SW. Spontaneous bacterial peritonitis. Hepatology 1982; 2:399S-407S.
XX. Malinchoc M, Gines P, Navasa M, et al. The model for end- stage liver disease (MELD) score predicts survival in patients with spontaneous bacterial peritonitis, and with ascites. Gastroenterology 2001;120: A378.
XXI. Malinchoc M, Gines P, Navasa M, et al. The model for end- stage liver disease (MELD) score predicts survival in patients with spontaneous bacterial peritonitis, and with ascites. Gastroenterology 2001;120: A378.
XXII. Evans LT, Kim WR, Poterucha JJ, Kamath PS. Spontaneous bacterial peritonitis in asymptomatic outpatients with cirrhosis ascites. Hepatology 2003; 37:897-901.
XXIII. Fernández J, Tandon P, Mensa J, Garcia-Tsao G. Antibiotic prophylaxis in cirrhosis: good and bad. Hepatology. 2016;63(6):2019–2031.
XXIV. Larson AM. Diagnosis and Management of Chronic Liver Diseases, An Issue of Medical Clinics. Elsevier Health Sciences; 2014.
XXV. L. Piroth, A, Pechinot, A. Minello et al, "Bacterial epidemiology and antimicrobial resistance in ascetic fluid: a 2-year retrospective study," Scandinavian Journal of Infectious Diseases, vol.41, no.11-12, pp847-851, 2009.
XXVI. 26.E. Ardolino, SSWang, and VRPatwardhan, "Evidence of significant ceftriaxone and quinolone resistance in cirrhotics with spontaneous bacterial peritonitis." Digestive Diseases and Sciences, vol. 64, no. 8, pp. 2359-2367, 2019.